Jody Law
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jody Law has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Christopher J. Dy
Department of Orthopaedic Surgery, Washington University in St. Louis, Saint Louis, MO
1 shared publication - Clare E. Wise
Stanford University School of Medicine, California, United States
1 shared publication Jeffrey Yao
Stanford University School of Medicine, California, United States
1 shared publication- Jun-Ku Lee
Department of Orthopaedic Surgery, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea
1 shared publication - Katherine E. Cavanaugh
Department of Orthopaedic Surgery, Washington University in St. Louis, St. Louis, Missouri
1 shared publication - Katherine Shehadeh
Tel-Aviv Medical Center, Israel
1 shared publication
Latest Publications
- 21 August 2026
- Published by Georg Thieme Verlag KG in Journal of Wrist Surgery
Need for Secondary Ulnar Shortening Osteotomy after Arthroscopic TFCC Debridement/Repair in Patients with Ulnar Positive Variance
Although studies have suggested a negative effect of positive ulnar variance on outcomes after adequate arthroscopic triangular fibrocartilage complex (TFCC) management, the exact clinical impact of ulnar positive variance remains inconclusive. The purpose of this study was to determine the rate of subsequent ulnar shortening osteotomy (USO) after arthroscopic management of TFCC pathology in ulnar-positive wrists and to identify factors associated with progression to USO. This retrospective cohort study included 150 wrists with positive ulnar variance that underwent arthroscopic TFCC debridement or repair by a single surgeon between 2005 and 2025 after application of the exclusion criteria. Patients were stratified based on whether secondary USO was performed during follow-up. Baseline demographics, radiographic ulnar variance, index arthroscopic procedure type, and adjunct procedures were compared between groups. Univariable logistic regression was performed to explore factors associated with subsequent USO. The mean preoperative ulnar variance was 1.74 ± 0.77 mm (range, 0.5–4.0 mm). Arthroscopic repair was performed in 90 wrists (60%) and debridement in 60 wrists (40%). During follow-up, 12 wrists (8%) underwent secondary USO at a median of 8.2 months after index arthroscopy. Baseline demographics, the degree of ulnar variance, and the index arthroscopic procedure type were not associated with progression to USO. In contrast, full-thickness lunate chondral defects requiring microfracture at the index arthroscopy were more common in wrists that later underwent USO than in those that did not (25% vs. 3.6%; p = 0.018). In univariable regression analysis, lunate microfracture was associated with subsequent USO, although this finding should be interpreted cautiously given the small number of events. Among ulnar-positive wrists treated arthroscopically for TFCC pathology, the observed proportion of subsequent USO was 8%. Baseline demographics and the degree of ulnar variance were not associated with progression to USO. Full-thickness lunate chondral defects requiring microfracture at the index arthroscopy were more frequently observed in wrists that later underwent USO. IV, therapeutic study.
- 21 August 2026
- Published by Georg Thieme Verlag KG in Journal of Wrist Surgery
Need for Secondary Ulnar Shortening Osteotomy after Arthroscopic TFCC Debridement/Repair in Patients with Ulnar Positive Variance
Although studies have suggested a negative effect of positive ulnar variance on outcomes after adequate arthroscopic triangular fibrocartilage complex (TFCC) management, the exact clinical impact of ulnar positive variance remains inconclusive. The purpose of this study was to determine the rate of subsequent ulnar shortening osteotomy (USO) after arthroscopic management of TFCC pathology in ulnar-positive wrists and to identify factors associated with progression to USO. This retrospective cohort study included 150 wrists with positive ulnar variance that underwent arthroscopic TFCC debridement or repair by a single surgeon between 2005 and 2025 after application of the exclusion criteria. Patients were stratified based on whether secondary USO was performed during follow-up. Baseline demographics, radiographic ulnar variance, index arthroscopic procedure type, and adjunct procedures were compared between groups. Univariable logistic regression was performed to explore factors associated with subsequent USO. The mean preoperative ulnar variance was 1.74 ± 0.77 mm (range, 0.5–4.0 mm). Arthroscopic repair was performed in 90 wrists (60%) and debridement in 60 wrists (40%). During follow-up, 12 wrists (8%) underwent secondary USO at a median of 8.2 months after index arthroscopy. Baseline demographics, the degree of ulnar variance, and the index arthroscopic procedure type were not associated with progression to USO. In contrast, full-thickness lunate chondral defects requiring microfracture at the index arthroscopy were more common in wrists that later underwent USO than in those that did not (25% vs. 3.6%; p = 0.018). In univariable regression analysis, lunate microfracture was associated with subsequent USO, although this finding should be interpreted cautiously given the small number of events. Among ulnar-positive wrists treated arthroscopically for TFCC pathology, the observed proportion of subsequent USO was 8%. Baseline demographics and the degree of ulnar variance were not associated with progression to USO. Full-thickness lunate chondral defects requiring microfracture at the index arthroscopy were more frequently observed in wrists that later underwent USO. IV, therapeutic study.
- 21 December 2022
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 105 (5) , 363-368
Catastrophic Health Expenditure in Patients with Lower-Extremity Orthopaedic Trauma
Background: Health-care expenditures are a leading contributor to financial hardship in the United States. Traumatic orthopaedic injuries are unpredictable and result in substantial expense. Our objectives were to quantify the catastrophic health expenditure (CHE) risk of patients with orthopaedic trauma and to examine the impact of insurance status, socioeconomic status, sex, and race on CHE. Methods: We identified all isolated lower-extremity orthopaedic trauma cases at a safety-net, Level-1 trauma center from 2018 to 2020. We queried an institutional charge database to obtain total hospital charges, insurance status, and ZIP Code to determine out-of-pocket (OOP) expenditures. To evaluate financial hardship, we calculated the CHE risk as defined by the World Health Organization’s threshold of OOP expenditures, ≥40% of estimated household post-subsistence income. Results: In our cohort of 2,535 patients, 33% experienced a risk of CHE. A risk of CHE was experienced by 99% of patients who were uninsured, 35% of patients with private insurance, 2% of patients with Medicare, and 0% of patients with Medicaid. Multivariable regression modeling showed that patients who were uninsured were significantly more likely to experience a risk of CHE compared with patients with private insurance (odds ratio, 107.68 [95% confidence interval, 37.20 to 311.68]; p < 0.001). Conclusions: One-third of patients with lower-extremity orthopaedic trauma experience a risk of CHE, with patients who are uninsured facing a disproportionately higher risk of CHE compared with patients who are insured. Our results suggest that the expansion of public insurance options may provide substantial financial protection for those at the greatest risk for CHE. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 21 December 2022
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 105 (5) , 363-368
Catastrophic Health Expenditure in Patients with Lower-Extremity Orthopaedic Trauma
Background: Health-care expenditures are a leading contributor to financial hardship in the United States. Traumatic orthopaedic injuries are unpredictable and result in substantial expense. Our objectives were to quantify the catastrophic health expenditure (CHE) risk of patients with orthopaedic trauma and to examine the impact of insurance status, socioeconomic status, sex, and race on CHE. Methods: We identified all isolated lower-extremity orthopaedic trauma cases at a safety-net, Level-1 trauma center from 2018 to 2020. We queried an institutional charge database to obtain total hospital charges, insurance status, and ZIP Code to determine out-of-pocket (OOP) expenditures. To evaluate financial hardship, we calculated the CHE risk as defined by the World Health Organization’s threshold of OOP expenditures, ≥40% of estimated household post-subsistence income. Results: In our cohort of 2,535 patients, 33% experienced a risk of CHE. A risk of CHE was experienced by 99% of patients who were uninsured, 35% of patients with private insurance, 2% of patients with Medicare, and 0% of patients with Medicaid. Multivariable regression modeling showed that patients who were uninsured were significantly more likely to experience a risk of CHE compared with patients with private insurance (odds ratio, 107.68 [95% confidence interval, 37.20 to 311.68]; p < 0.001). Conclusions: One-third of patients with lower-extremity orthopaedic trauma experience a risk of CHE, with patients who are uninsured facing a disproportionately higher risk of CHE compared with patients who are insured. Our results suggest that the expansion of public insurance options may provide substantial financial protection for those at the greatest risk for CHE. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 5 October 2021
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 191 (1) , 77-86
Breast reconstruction is a viable option for older patients
Purpose Breast cancer is diagnosed at a median age of 62 years in the USA. At the same time, mortality rates for breast cancer continue to decrease, falling by 40% from 1989 to 2016. In the coming decades, the number of elderly patients with breast cancer, potentially seeking reconstruction, is expected to increase. Methods A retrospective chart review of 309 patients, aged 60 years or older, undergoing immediate or delayed breast reconstruction, was conducted. Patient characteristics, clinical information and major complications requiring reoperation were evaluated. Multivariate analyses identified factors contributing to complications such as BMI, comorbidities, smoking status, history of previous breast conservation therapy (BCT), total expander volume, radiotherapy, and chemotherapy. Results 26.7% of patients had at least one complication requiring reoperation, and 6.9% of patients suffered reconstructive failure. Logistic regression analysis of all patients (n = 309) found a statistically significant relationship between major complication and history of ipsilateral BCT (p = 0.026) and adjuvant chemotherapy (p = 0.005). Logistic regression analysis in patients undergoing tissue expander (TE) reconstruction (n = 215) showed that major complications were related to BMI over 35 kg/m2 (p = 0.04), history of ipsilateral BCT (p = 0.048), and adjuvant chemotherapy (p = 0.033). Conclusion Breast reconstruction in women over 60 years old was not independently associated with higher major complication rates in our series.
- 5 October 2021
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 191 (1) , 77-86
Breast reconstruction is a viable option for older patients
Purpose Breast cancer is diagnosed at a median age of 62 years in the USA. At the same time, mortality rates for breast cancer continue to decrease, falling by 40% from 1989 to 2016. In the coming decades, the number of elderly patients with breast cancer, potentially seeking reconstruction, is expected to increase. Methods A retrospective chart review of 309 patients, aged 60 years or older, undergoing immediate or delayed breast reconstruction, was conducted. Patient characteristics, clinical information and major complications requiring reoperation were evaluated. Multivariate analyses identified factors contributing to complications such as BMI, comorbidities, smoking status, history of previous breast conservation therapy (BCT), total expander volume, radiotherapy, and chemotherapy. Results 26.7% of patients had at least one complication requiring reoperation, and 6.9% of patients suffered reconstructive failure. Logistic regression analysis of all patients (n = 309) found a statistically significant relationship between major complication and history of ipsilateral BCT (p = 0.026) and adjuvant chemotherapy (p = 0.005). Logistic regression analysis in patients undergoing tissue expander (TE) reconstruction (n = 215) showed that major complications were related to BMI over 35 kg/m2 (p = 0.04), history of ipsilateral BCT (p = 0.048), and adjuvant chemotherapy (p = 0.033). Conclusion Breast reconstruction in women over 60 years old was not independently associated with higher major complication rates in our series.